ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 662,30
0,00%
Dow Jones
39 112,16
-0,76%
DAX
18 177,62
-0,90%
Brent Oil
84,66
0,56%
Bitcoin
61 606,23
-0,32%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Carmell Corporation (CTCX)

  7. Carmell Corporation (CTCX) Actualités

CTCX

Carmell (CTCX)

Carmell Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CTCX
DateHeureSourceTitreSymboleSociété
11/04/202422h30GlobeNewswire Inc.Carmell Announces Successful Closing of $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
04/04/202414h30GlobeNewswire Inc.Carmell Announces $3.0 Million Private PlacementNASDAQ:CTCXCarmell Corporation
27/03/202414h15GlobeNewswire Inc.Carmell Announces Successful Closing of Axolotl Biologix Sale TransactionNASDAQ:CTCXCarmell Corporation
20/03/202421h39GlobeNewswire Inc.Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix SubsidiaryNASDAQ:CTCXCarmell Corporation
18/03/202420h16GlobeNewswire Inc.Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics FieldNASDAQ:CTCXCarmell Corporation
26/02/202414h30GlobeNewswire Inc.Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024NASDAQ:CTCXCarmell Corporation
05/01/202422h39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTCXCarmell Corporation
19/12/202323h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
08/12/202322h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTCXCarmell Corporation
16/11/202314h30GlobeNewswire Inc.Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of DirectorsNASDAQ:CTCXCarmell Corporation
15/11/202322h56Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CTCXCarmell Corporation
25/10/202322h02Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CTCXCarmell Corporation
12/09/202318h35PR Newswire (US)Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative MedicineNASDAQ:CTCXCarmell Corporation
06/09/202300h03GlobeNewswire Inc.Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on AestheticsNASDAQ:CTCXCarmell Corporation
14/08/202323h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTCXCarmell Corporation
09/08/202321h41Business WireCarmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand IdentityNASDAQ:CTCXCarmell Corporation
07/08/202323h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CTCXCarmell Corporation
27/07/202313h00Business WireCarmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine CompanyNASDAQ:CTCXCarmell Corporation
 Showing the most relevant articles for your search:NASDAQ:CTCX

Dernières Valeurs Consultées

EU
PX1
CAC 40
EU
CS
Axa
USI
USTECH100
US Tech 100
SPI
SP500
S&P 500
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
EU
VK
Vallourec
EU
LR
Legrand
EU
BNP
BNP Paribas
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
NASDAQ
AAPL
Apple
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés